The immunogenic effects of VEGF targeted therapy: Fact or fiction?

Date 07 December 2017
Event ESMO Immuno-Oncology Congress 2017
Session Combining immune checkpoint inhibitors and VEGF targeted therapies in cancer treatment
Topics Gastric Cancer
Gastrointestinal Cancers
Lung and other Thoracic Tumours
Translational Research
Presenter Thomas Powles
Authors T. Powles
  • Oncology, St. Bartholomew's Hospital, EC1A 7BE - London/GB